Streetbeat News

Products Services

JKHY

First Federal Bank of Kansas City (FFBKC) has selected Jack Henry (NASDAQ: JKHY) to enhance customer experience, boost efficiencies, and expand small business services. This partnership aims to drive growth and innovation for the mutual bank.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 12:01 pm

MRUS

Merus N.V. has dosed the first patient in its Phase 2 trial of Petosemtamab for second-line metastatic colorectal cancer. The Biclonics therapy targets EGFR and LGR5.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 12:01 pm

ACET

Adicet Bio shares are trading higher after the company announced that the FDA granted it Fast Track Designation to ADI-270 for the potential treatment of patients with metastatic/advanced clear cell renal cell carcinoma.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 11:57 am

FRSX

Foresight Autonomous Holdings Ltd. (FRSX) has signed an amendment to an existing agreement with SUNWAY-AI Technology to integrate its ScaleCam stereoscopic vision system into SUNWAY's autonomous logistics and robotic vehicles. This integration aims to enhance the efficiency and safety of logistical operations. The first batch of ScaleCam systems is expected to be supplied by the end of 2024, pending SUNWAY's approval.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 11:55 am

BABA

MSFT

Alibaba and SenseTime showcased significant AI advancements at the World Artificial Intelligence Conference in Shanghai. SenseTime's new SenseNova 5.5 LLM outperformed GPT-4 in key metrics, while Alibaba's cloud computing unit saw substantial growth in user numbers and customer engagement. Baidu's recent launch of Ernie 4.0 Turbo has intensified competition in the AI market.

Portfolio Pulse from Anusuya Lahiri

July 08, 2024 | 11:44 am

HLVX

HilleVax, Inc. (NASDAQ:HLVX) announced that its Phase 2b NEST-IN1 study of the norovirus vaccine HIL-214 in infants did not meet its primary efficacy endpoint. The study showed a vaccine efficacy of 5%, with no clinical benefit observed across secondary endpoints. HilleVax plans to discontinue further development of HIL-214 in infants but will explore its potential in adults.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 11:35 am

KA

Kineta shares are trading higher after announcing an exclusivity and right of first offer agreement with TuHURA Biosciences for its Anti-VISTA antibody.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 11:34 am

CASI

CASI Pharmaceuticals (NASDAQ:CASI) has appointed Dr. Daniel Lang as its new Chief Financial Officer and Senior Vice President, effective July 8th, 2024. Dr. Lang brings over 30 years of experience in the biotech sector, including roles as a physician scientist, investor, and executive.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 11:33 am

AMRN

Amarin's China partner EddingPharm has received regulatory approval from the NMPA for VASCEPA in mainland China for cardiovascular risk reduction.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 11:33 am

RILY

B. Riley Financial (NASDAQ:RILY) has acquired Interface Consulting International, a leading engineering and construction consulting firm. The financial terms of the acquisition were not disclosed. Interface Consulting will join B. Riley Advisory Services, enhancing the firm's professional services offerings.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 11:32 am